Patient-Centered Adherence Intervention After Acute Coronary Syndrome Hospitalization
- 1 July 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 5 (4) , 571-576
Abstract
Background—: Adherence to cardioprotective medications in the year after acute coronary syndrome hospitalization is generally poor and is associated with increased risk of rehospitalization and mortality. Few interventions have specifically targeted this high-risk patient population to improve medication adherence. We hypothesize that a multifaceted patient-centered intervention could improve adherence to cardioprotective medications. Methods and Results—: To evaluate this intervention, we propose enrolling 280 patients with a recent acute coronary syndrome event into a multicenter randomized, controlled trial. The intervention comprises4 main components: (1) pharmacist-led medication reconciliation and tailoring; (2) patient education; (3) collaborative care between pharmacist and primary care provider/cardiologist; and (4) 2 types of voice messaging (educational and medication refill reminder calls). Patients in the intervention arm will visit with the study pharmacist ≈1 week post-hospital discharge. The pharmacist will work with the patient and collaborate with providers to reconcile medication issues. Voice messages will augment the educational process and remind patients to refill their cardioprotective medications. The study will compare the intervention versus usual care for 12 months. The primary outcome of interest is adherence using the ReComp method. Secondary and tertiary outcomes include achievement of targets for blood pressure and low-density lipoprotein, and reduction in the combined cardiovascular end points of myocardial infarction hospitalization, coronary revascularization, and all-cause mortality. Finally, we will also evaluate the cost-effectiveness of the intervention compared with usual care. Conclusions—: If the intervention is effective in improving medication adherence and demonstrating a lower cost, the intervention has the potential to improve cardiovascular outcomes in this high-risk patient population.Keywords
This publication has 25 references indexed in Scilit:
- Full Coverage for Preventive Medications after Myocardial InfarctionNew England Journal of Medicine, 2011
- A Randomized Trial of Direct-to-Patient Communication to Enhance Adherence to β-Blocker Therapy Following Myocardial InfarctionArchives of internal medicine (1960), 2008
- Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial InfarctionCirculation, 2008
- Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial InfarctionJAMA, 2007
- Impact of Medication Therapy Discontinuation on Mortality After Myocardial InfarctionArchives of internal medicine (1960), 2006
- Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent PlacementCirculation, 2006
- Use and adherence to beta‐blockers for secondary prevention of myocardial infarction: who is not getting the treatment?Pharmacoepidemiology and Drug Safety, 2004
- Interventions to Enhance Patient Adherence to Medication PrescriptionsJAMA, 2002
- Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up studyHeart, 2002
- Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary SyndromesJAMA, 2002